Genotoxic and cytotoxic effects of antibacterial drug, ciprofloxacin, on human lymphocytes in vitro.

Ciprofloxacin is a bactericidal drug which is being used widely throughout the world for the treatment of various bacterial infection. Cytotoxicity and genotoxicity of Ciprofloxacin on human lymphocytes in vitro had been assessed taking various parameters like mitotic index (MI), chromosome aberration (CA), anaphase anomalies, replicative index (RI) and sister chromatid exchange (SCE) as end points. Our results indicate low mitotic index, low replicative index and high frequency of anaphase anomalies on one hand and on other hand, high frequency of chromosome aberration and sister chromatid exchanges (SCEs) in the exposed groups as compared to that of control group. These are the indications of both cytotoxicity and genotoxicity of Ciprofloxacin on human lymphocyte culture in vitro. All the parameters obtained from the experimental group were statistically significant when compared to that of control.

[1]  K. Mitsumori,et al.  Genotoxic potential of quinolone antimicrobials in the in vitro comet assay and micronucleus test. , 2006, Mutation research.

[2]  İ. Pirim,et al.  Genotoxic Evaluation of the Antibacterial Drug, Ciprofloxacin, in Cultured Lymphocytes of Patients with Urinary Tract Infection , 2004 .

[3]  A. Camm,et al.  Quinolones: , 2003, Pacing and clinical electrophysiology : PACE.

[4]  I. Shalit,et al.  Immunomodulatory effects of quinolones. , 2003, The Lancet. Infectious diseases.

[5]  Jin-Hong Yoo,et al.  In Vitro Effects of Ciprofloxacin and Roxithromycin on Apoptosis of Jurkat T Lymphocytes , 2003, Antimicrobial Agents and Chemotherapy.

[6]  N. Gorla,et al.  Ciprofloxacin increases hepatic and renal lipid hydroperoxides levels in mice. , 2002, Biocell : official journal of the Sociedades Latinoamericanas de Microscopia Electronica ... et. al.

[7]  I. Larripa,et al.  Chromosomal aberrations in human lymphocytes exposed in vitro to enrofloxacin and ciprofloxacin. , 1999, Toxicology letters.

[8]  H. Lode,et al.  Safety of quinolones , 1998, The Lancet.

[9]  J. Remington,et al.  Effect of Trovafloxacin on Production of Cytokines by Human Monocytes , 1998, Antimicrobial Agents and Chemotherapy.

[10]  J. Theiss,et al.  In vitro induction of micronuclei and chromosome aberrations by quinolones: possible mechanisms. , 1996, Mutation research.

[11]  A. Pino.  Induction of sperm abnormalities and dominant lethal effects in mice treated with ciprofloxacin , 1995 .

[12]  A. Mukherjee,et al.  Ciprofloxacin: mammalian DNA topoisomerase type II poison in vivo. , 1993, Mutation research.

[13]  C. Downes,et al.  Inhibitors of DNA topoisomerase II prevent chromatid separation in mammalian cells but do not prevent exit from mitosis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[14]  R. J. Reece,et al.  DNA gyrase: structure and function. , 1991, Critical reviews in biochemistry and molecular biology.

[15]  T. Gootz,et al.  In vitro assays used to measure the activity of topoisomerases , 1990, Antimicrobial Agents and Chemotherapy.

[16]  T. Gootz,et al.  Inhibitory effects of quinolone antibacterial agents on eucaryotic topoisomerases and related test systems , 1990, Antimicrobial Agents and Chemotherapy.

[17]  T. Gootz,et al.  Biochemical characteristics and physiological significance of major DNA topoisomerases , 1989, Antimicrobial Agents and Chemotherapy.

[18]  A. Forsgren,et al.  4-Quinolone antibiotics: positive genotoxic screening tests despite an apparent lack of mutation induction. , 1989, Mutation research.

[19]  P. Muehlbauer,et al.  Genetic profile of a nalidixic acid analog: A model for the mechanism of sister chromatid exchange induction , 1989, Environmental and molecular mutagenesis.

[20]  A. Forsgren,et al.  Effects of ciprofloxacin on eucaryotic pyrimidine nucleotide biosynthesis and cell growth , 1987, Antimicrobial Agents and Chemotherapy.

[21]  F. Grosse,et al.  Effect of 4-quinolones and novobiocin on calf thymus DNA polymerase alpha primase complex, topoisomerases I and II, and growth of mammalian lymphoblasts , 1986, Antimicrobial Agents and Chemotherapy.

[22]  S. Gollapudi,et al.  Effect of ciprofloxacin on mitogen-stimulated lymphocyte proliferation , 1986, Antimicrobial Agents and Chemotherapy.

[23]  D. Reeves,et al.  In-vitro studies with ciprofloxacin, a new 4-quinolone compound. , 1984, The Journal of antimicrobial chemotherapy.

[24]  P. Perry,et al.  Cytological detection of mutagen–carcinogen exposure by sister chromatid exchange , 1975, Nature.